Neuren Pharmaceuticals Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of NURPF for the last semiannual is 115.05 M USD, and it's 174.53% higher compared to the previous semiannual. The net income of H2 23 is 74.39 M USD.